These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24821285)

  • 1. microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells.
    Ren Y; Han X; Yu K; Sun S; Zhen L; Li Z; Wang S
    Mol Med Rep; 2014 Jul; 10(1):315-21. PubMed ID: 24821285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells.
    Liu S; Zhang P; Chen Z; Liu M; Li X; Tang H
    FEBS Lett; 2013 Jul; 587(14):2247-53. PubMed ID: 23742934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
    Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.
    Chu J; Li Y; Fan X; Ma J; Li J; Lu G; Zhang Y; Huang Y; Li W; Huang X; Fu Z; Yin Y; Yuan H
    Cell Physiol Biochem; 2018; 48(2):593-604. PubMed ID: 30021199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-200c regulates the proliferation, apoptosis and invasion of gastric carcinoma cells through the downregulation of EDNRA expression.
    Wei W; Shi L; Chen W; Hu L; Chen D; Shi X; Xiang H; Guo C; Wu Z
    Int J Mol Med; 2018 Mar; 41(3):1619-1626. PubMed ID: 29286062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
    Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
    Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.
    Erturk E; Cecener G; Tezcan G; Egeli U; Tunca B; Gokgoz S; Tolunay S; Tasdelen I
    Gene; 2015 Feb; 556(2):163-9. PubMed ID: 25445393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
    Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
    Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel microRNA hsa-miR-CHA1 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP.
    Yoo JK; Lee JM; Kang SH; Jeon SH; Kim CM; Oh SH; Kim CH; Kim NK; Kim JK
    Lung Cancer; 2019 Jun; 132():99-106. PubMed ID: 31097102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer.
    Wu Q; Chen Z; Zhang G; Zhou W; Peng Y; Liu R; Chen C; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):693-700. PubMed ID: 29790898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C; Yan B; Lu Q; Lin Y; Ma L
    Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
    Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
    Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs-mediated cell fate in triple negative breast cancers.
    Sui X; Wang X; Han W; Li D; Xu Y; Lou F; Zhou J; Gu X; Zhu J; Zhang C; Pan H
    Cancer Lett; 2015 May; 361(1):8-12. PubMed ID: 25748387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo.
    Jiang C; Tan T; Yi XP; Shen H; Li YX
    Mol Med Rep; 2011; 4(4):667-74. PubMed ID: 21479361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.